Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Geoffrey Smith
Stay informed with Geoffrey Smith’s coverage and analysis for Fortune.
Page 74 of 100
International
Toyota’s earnings shortfall adds insult to injury
By
Geoffrey Smith
Obama’s final emissions rule sets up a fight with states, GOP
By
Geoffrey Smith
International
Ex-UBS trader Tom Hayes gets 14 years for rigging Libor
By
Geoffrey Smith
International
Why Greece’s stock market just dropped more than 20%
By
Geoffrey Smith
Finance
HSBC sells up in Brazil as compliance costs crimp global ambitions
By
Geoffrey Smith
International
Vladimir Putin thinks FIFA’s Blatter deserves a Nobel Prize
By
Geoffrey Smith
Features
The Fed, GM and a Twitter update–5 things to know today
By
Laura Lorenzetti
and
Geoffrey Smith
BP swings to $5.8 billion loss on Gulf charge, oil slide
By
Geoffrey Smith
International
Varoufakis’ Plan B was worse than a crime – it was half-baked nonsense
By
Geoffrey Smith
International
Israeli drug firm Teva buys Allergan’s generics business for $40 billion
By
Geoffrey Smith
Features
ISIS and drug sales — 5 things to know today
By
Tom Huddleston Jr.
and
Geoffrey Smith
International
China’s slowdown pushes commodity prices to new lows
By
Geoffrey Smith
International
The SEC thinks Guinness brewer Diageo may be spiking its results
By
Geoffrey Smith
International
Europe’s antitrust regulators cry foul over Hollywood’s pay-TV deals
By
Geoffrey Smith
Features
Bank of America and Amazon earnings — 5 things to know today
By
Tom Huddleston Jr.
and
Geoffrey Smith